4 articles tagged with #ai-drug-discovery. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
Two AI-based science assistants have demonstrated success in drug-retargeting tasks, with both tools capable of generating hypotheses and one additionally analyzing relevant data. This advancement showcases AI's growing role in accelerating pharmaceutical research and drug discovery processes.
Filippo Menolascina leverages Co-Scientist AI to accelerate the discovery of liver disease mechanisms and identify new treatment options. The research aims to explain why certain existing drugs are effective only for specific patient populations, potentially enabling more personalized therapeutic approaches.
Johnson & Johnson's CEO highlights America's competitive edge in healthcare innovation, citing AI-driven drug discovery and a $55 billion domestic manufacturing investment as evidence of the U.S. health innovation engine's momentum and future potential.
Taiwanese biopharmaceutical company Senhwa Biosciences has secured up to $16 million in funding from GEM through a memorandum of understanding to accelerate AI-driven drug discovery. This partnership represents growing institutional investment in combining artificial intelligence with pharmaceutical development to expedite clinical-stage research.
